More reasons to use SGLT2 inhibitors: EMPEROR-Reduced and DAPA-CKD

Refers to:

Source: Kidney International - October 14, 2020 Category: Urology & Nephrology Authors: Masaomi Nangaku Tags: nephrology digest Source Type: research